FI915891A0 - Immunoaktiva peptider och antikroppar samt deras anvaendning till antiallergisk behandling. - Google Patents

Immunoaktiva peptider och antikroppar samt deras anvaendning till antiallergisk behandling.

Info

Publication number
FI915891A0
FI915891A0 FI915891A FI915891A FI915891A0 FI 915891 A0 FI915891 A0 FI 915891A0 FI 915891 A FI915891 A FI 915891A FI 915891 A FI915891 A FI 915891A FI 915891 A0 FI915891 A0 FI 915891A0
Authority
FI
Finland
Prior art keywords
immunoaktiva
antiallergisk
antikroppar
peptider
behandling
Prior art date
Application number
FI915891A
Other languages
English (en)
Other versions
FI104723B (fi
Inventor
Denis Raymond Stanworth
Ian Victor Lewin
Sarita Nayyar
Valerie Jones
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of FI915891A0 publication Critical patent/FI915891A0/fi
Application granted granted Critical
Publication of FI104723B publication Critical patent/FI104723B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI915891A 1989-06-15 1991-12-13 Menetelmä immunoaktiivisten peptidien valmistamiseksi FI104723B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8913737 1989-06-15
GB898913737A GB8913737D0 (en) 1989-06-15 1989-06-15 A novel anti-allergy treatment
PCT/GB1990/000926 WO1990015878A1 (en) 1989-06-15 1990-06-15 Immunoactive peptides and antibodies and their use in anti-allergy treatment
GB9000926 1990-06-15

Publications (2)

Publication Number Publication Date
FI915891A0 true FI915891A0 (fi) 1991-12-13
FI104723B FI104723B (fi) 2000-03-31

Family

ID=10658467

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915891A FI104723B (fi) 1989-06-15 1991-12-13 Menetelmä immunoaktiivisten peptidien valmistamiseksi

Country Status (18)

Country Link
US (1) US5601821A (fi)
EP (2) EP0403312A1 (fi)
JP (2) JPH04505922A (fi)
KR (1) KR0181313B1 (fi)
AT (1) ATE122401T1 (fi)
CA (1) CA2057860C (fi)
DE (1) DE69019348T2 (fi)
DK (1) DK0477231T3 (fi)
ES (1) ES2073028T3 (fi)
FI (1) FI104723B (fi)
GB (2) GB8913737D0 (fi)
IE (1) IE71677B1 (fi)
NO (1) NO914937L (fi)
NZ (1) NZ234085A (fi)
PH (1) PH30233A (fi)
PT (1) PT94381B (fi)
WO (1) WO1990015878A1 (fi)
ZA (1) ZA904670B (fi)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955076A (en) * 1989-06-15 1999-09-21 Peptide Therapeutics Limited Immunoactive peptides and antibodies and their use in anti-allergy treatment
SE9102808L (sv) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
JP3156237B2 (ja) * 1991-12-24 2001-04-16 雪印乳業株式会社 抗ヒトＩｇＥ モノクローナル抗体
US6066718A (en) * 1992-09-25 2000-05-23 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
US5958708A (en) * 1992-09-25 1999-09-28 Novartis Corporation Reshaped monoclonal antibodies against an immunoglobulin isotype
JPH06113881A (ja) * 1992-10-07 1994-04-26 Snow Brand Milk Prod Co Ltd ヒト型モノクローナル抗ペプチド抗体及びこれをコードするｄｎａ
AU5957794A (en) * 1992-12-21 1994-07-19 Uab Research Foundation, The Compositions and method for the inhibition of phagocytes
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
DK0708656T3 (da) * 1993-04-27 2002-12-02 United Biomedical Inc Antigene LHRH peptidkonstruktioner og universelle syntetiske immunstimulatorer til vacciner
WO1995026365A1 (en) * 1994-03-28 1995-10-05 United Biomedical, Inc. Synthetic peptide based immunogens for the treatment of allergy
GB9412714D0 (en) * 1994-06-24 1994-08-17 Lewin Ian V T cill epitopes
GB9416321D0 (en) * 1994-08-12 1994-10-05 Peptide Therapeutics Ltd Peptides and antibodies and their use in treatment of carcinomas
GB9417086D0 (en) * 1994-08-24 1994-10-12 Peptide Therapeutrics Limited Screen for potential therapeutic compounds
GB9422294D0 (en) * 1994-11-04 1994-12-21 Peptide Therapeutics Ltd Peptides for anti-allergy treatment
GB2304347A (en) 1995-08-11 1997-03-19 Boeringer Ingelheim Vetmedica Antigenic preparations
DE69718150T3 (de) 1996-03-01 2009-03-05 Novartis Ag Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
EP0904031A4 (en) * 1996-05-29 2002-05-02 Cell Genesys Inc CATIONIC POLYMERS / LIPIDS AS VEHICLES FOR PROVIDING NUCLEIC ACID
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US6573372B2 (en) 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of
US6887472B2 (en) 2000-08-30 2005-05-03 Pfizer Inc. Anti-IgE vaccines
US7320793B2 (en) * 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
JP2003047482A (ja) * 2001-05-22 2003-02-18 Pfizer Prod Inc 非アナフィラキシー誘発性ＩｇＥワクチン
DE60234375D1 (de) 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
BR0312792A (pt) 2002-07-19 2005-05-03 Cytos Biotechnology Ag Composições de vacinas contendo séries antigênicas de amilóide beta1-6
ATE536188T1 (de) 2002-08-14 2011-12-15 Macrogenics Inc Fcgammariib-spezifische antikörper und verfahren zur verwendung davon
DE602005012097D1 (de) 2004-04-26 2009-02-12 Innate Pharma Adjuvante zusammensetzung und anwendungsverfahren dafür
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
SI2032592T1 (sl) 2006-06-12 2013-10-30 Cytos Biotechnology Ag Postopki za pakiranje oligonukleotidov v virusu-podobne delce RNA bakteriofagov
PL2029173T3 (pl) 2006-06-26 2017-04-28 Macrogenics, Inc. Przeciwciała swoiste dla FC RIIB i sposoby ich zastosowania
EP2401300B1 (en) * 2009-02-25 2018-01-10 Academia Sinica ANTI-C[epsilon]mX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES
US9587034B2 (en) 2012-04-20 2017-03-07 Academia Sinica Anti-mIgE antibodies that bind to the junction between CH4 and CεmX domains
PT3430390T (pt) * 2016-03-18 2022-11-08 Genclis Origem molecular da alergia
AU2018360999A1 (en) 2017-10-31 2020-05-14 Oneness Biotech Co. Ltd. Treating IgE-mediated allergic diseases
JP7503857B2 (ja) * 2022-04-11 2024-06-21 緑茵生技股▲ふん▼有限公司 抗アレルギー性ペプチド及びその免疫調節と抗アレルギーに用いられる用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
EP0000252B1 (en) * 1977-06-29 1982-02-03 Beecham Group Plc Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
EP0344211A4 (en) * 1987-02-20 1990-03-12 Imclone Systems Inc MONOCLONAL ANTIBODIES IN VACCINE COMPOSITIONS.
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤
WO1991019001A1 (en) * 1990-05-25 1991-12-12 British Technology Group Ltd Immunodiagnostic assay for rheumatoid arthritis
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
EP0477231A1 (en) 1992-04-01
PH30233A (en) 1997-02-05
IE902154L (en) 1990-12-15
CA2057860A1 (en) 1990-12-16
PT94381A (pt) 1991-02-08
AU5814890A (en) 1991-01-08
GB8913737D0 (en) 1989-08-02
KR920702723A (ko) 1992-10-06
ATE122401T1 (de) 1995-05-15
KR0181313B1 (ko) 1999-04-01
FI104723B (fi) 2000-03-31
JP2000152783A (ja) 2000-06-06
NO914937L (no) 1991-12-19
DK0477231T3 (da) 1995-07-10
US5601821A (en) 1997-02-11
DE69019348D1 (de) 1995-06-14
EP0403312A1 (en) 1990-12-19
IE902154A1 (en) 1991-01-02
NO914937D0 (no) 1991-12-13
AU646808B2 (en) 1994-03-10
JPH04505922A (ja) 1992-10-15
EP0477231B1 (en) 1995-05-10
GB9013478D0 (en) 1990-08-08
IE71677B1 (en) 1997-02-26
PT94381B (pt) 1996-11-29
CA2057860C (en) 2000-05-09
DE69019348T2 (de) 1995-09-21
ZA904670B (en) 1992-02-26
NZ234085A (en) 1991-09-25
ES2073028T3 (es) 1995-08-01
WO1990015878A1 (en) 1990-12-27

Similar Documents

Publication Publication Date Title
FI915891A0 (fi) Immunoaktiva peptider och antikroppar samt deras anvaendning till antiallergisk behandling.
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
ZA837603B (en) Immunogenic protein or peptide complex,method of producing said complex and the use thereof as an immune stimulant and as a vaccine
EP0855918A4 (en) INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
ATE118784T1 (de) Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen.
SE8008415L (sv) Cyklisk analog for fagocytosstimulerande naturpeptid, dvs treonyl-cyklo-(-n-lysyl-prolyl-arginyl-)
NO870476D0 (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
PH31198A (en) Protein recognized by antibodies raised against native P28 of schitosoma mansoni.
DK665688A (da) Polypeptid
NO175639C (no) Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet
ZA856655B (en) Cross-reactive and protective epitopes of circumsporozoite proteins
ES2051647A1 (es) Procedimiento para la preparacion de calcitonina de salmon.
MY131433A (en) Novel metazoan parasite antigens having pepstatin binding activity and their use in vaccines
EP0350218A3 (en) Monoclonal antibodies recognizing gamma atrial natriuretic polypeptide, hybridomas producing such antibodies, and their preparation and use
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
EP0351244A3 (en) Antibodies and methods for immunochemical assay using them
IL96215A0 (en) Monoclonal antibodies directed against an antigenic protein or an antigenic polypeptide obtained from the sporocysts of eimeria tenella,antiidiotypic antibodies directed against said monoclonal antibodies and methods for conferring upon a chicken passive or active immunity to diseases caused by eimeria tenella and eimeria necatrix by administration of said monoclonal or anti-idiotypic antibodies to said chicken
DE3890354T1 (de) Synthetisches polypeptid mit grippevirus-antigenreaktivitaet

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PEPTIDE THERAPEUTICS LIMITED

GB Transfer or assigment of application

Owner name: PEPTIDE THERAPEUTICS LIMITED